Replies to post #27089 on Lifeline Biotechnologies Inc (LLBO)

[LEFTY1182]

I think it’s all going to happen at one time. They are definitely up to something.

[confirm]

Well well we’ll looks like Cyrcadia Health/Asia are feeling a little pressure...
Wonder why that is, how about women in the US want the iTBra 1:61 chance of
invasive breast cancer odds, why not try to beat em...?
But, your questions r spot on why did CA respond & not CH, several reasons:
1) CH website is currently under revision, so obviously the Not for sale in US AT THIS TIME statement
Can’t be posted there...
2) There has been much push threw going on with various contact sites- twitter, Facebook, direct email to quite a few large organizations, Doctors,AARP, Cancer causes, etc., recently (Rob Royea product release date/pricing live interview with HKIBN,
etc etc.) May have created many inquiries??? —-Everyone has done their job—-

Mead may be spot on with CH website re-launch & USA iTBra FDA OTC approval since they
already have FDA Class11 approval (& if anyone says they don’t have FDA Class11 “ go jump in a lake & hold your breath” or
do some research.) I added in the FDA Over the Counter approval because that is exactly what they
are working on with the FDA. Of course if indeed this was the case, I’m not sure if the ticker could move fast enough.
But, one thing I am beyond certain of is when the CH website reopens the iTBra will have launched SOMEWHERE ?


Conclusion: Let’s face it the iTBra is coming out of the cage, and everyone wants to see the Tiger!!! Tic tic tic...